Completion of toxicity study

  • 10:42

Immunicum successfully completes a larger toxicity study as, which is an important step towards receiving an approval from the Medical Products Agency to initiate its first clinical trial.

Injection of COMBIG cells into the kidneys of rats did not cause any effects on health status, haematology, clinical chemistry, or histopathology neither acutely, within days after injection, nor after a repeated administration.